New Mouse Models of, and AAV9 Gene Therapeutics to Treat, Isolated Methylmalonic Acidemia, Cobalamin B (cblB) Type

被引：0
|
作者：
Choi, Eun-Young [1 ]
Choi, Karenna [1 ]
Li, Lina [1 ]
Venditti, Charles P. [1 ]
机构：
[1] NHGRI, MMB, OARS, NIH, Bethesda, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
126
引用
收藏
页码：67 / 68
页数：2
相关论文
共 28 条
  • [11] Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease
    Du, Sichen
    Ou, Huayuan
    Cui, Renjie
    Jiang, Nan
    Zhang, Meiqin
    Li, Xiaorong
    Ma, Jing
    Zhang, Jin
    Ma, Duan
    HUMAN GENE THERAPY, 2019, 30 (02) : 155 - 167
  • [12] Effect of Nuclear Factor κB Inhibition on Serotype 9 Adeno-Associated Viral (AAV9) Minidystrophin Gene Transfer to the mdx Mouse
    Reay, Daniel P.
    Niizawa, Gabriela A.
    Watchko, Jon F.
    Daood, Molly
    Reay, Ja'Nean C.
    Raggi, Eugene
    Clemens, Paula R.
    MOLECULAR MEDICINE, 2012, 18 (03) : 466 - 476
  • [13] Effect of Nuclear Factor κB Inhibition on Serotype 9 Adeno-Associated Viral (AAV9) Minidystrophin Gene Transfer to the mdx Mouse
    Daniel P Reay
    Gabriela A Niizawa
    Jon F Watchko
    Molly Daood
    Ja’Nean C Reay
    Eugene Raggi
    Paula R Clemens
    Molecular Medicine, 2012, 18 : 466 - 476
  • [14] Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin
    Cheah, Pike-See
    Prabhakar, Shilpa
    Yellen, David
    Beauchamp, Roberta L.
    Zhang, Xuan
    Kasamatsu, Shingo
    Bronson, Roderick T.
    Thiele, Elizabeth A.
    Kwiatkowski, David J.
    Stemmer-Rachamimov, Anat
    Gyorgy, Bence
    Lin, King-Hwa
    Kaneki, Masao
    Tannous, Bakhos A.
    Ramesh, Vijaya
    Maguire, Casey A.
    Breakefield, Xandra O.
    SCIENCE ADVANCES, 2021, 7 (02)
  • [15] Gene Therapy for Tuberous Sclerosis Complex Type 2 in a Mouse Model by Delivery of AAV9 Encoding a Condensed Form of Tuberin
    Prabhakar, Shilpa
    MOLECULAR THERAPY, 2020, 28 (04) : 563 - 563
  • [16] AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease
    Chen, Xin
    Dong, Thomas
    Hu, Yuhui
    Shaffo, Frances C.
    Belur, Nandkishore R.
    Mazzulli, Joseph R.
    Gray, Steven J.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (05):
  • [17] AAV-Mediated Gene Therapy to Treat Mucopolysaccharidosis Type IVA in a New Morquio a Mouse Model
    Sanchez, Victor
    Bertolin, Joan
    Ribera, Albert
    Sanchez, Xavier
    Marco, Sara
    Motas, Sandra
    Perez, Jennifer
    Roca, Carles
    Elias, Gemma
    Garcia, Miquel
    Leon, Xavier
    Haurigot, Virginia
    Ruberte, Jesus
    Bosch, Fatima
    MOLECULAR THERAPY, 2020, 28 (04) : 492 - 492
  • [18] AAV-mediated gene therapy to treat mucopolysaccharidosis type IVA in a new mouse model of the disease
    Sanchez, V.
    Bertolin, J.
    Ribera, A.
    Sanchez, X.
    Marco, S.
    Motas, S.
    Perez, J.
    Roca, C.
    Elias, G.
    Garcia, M.
    Leon, X.
    Haurigot, V.
    Ruberte, J.
    Bosch, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A172 - A172
  • [19] Gene therapy for the treatment of Niemann-Pick disease type C1: Comparison of AAV9 to a novel serotype, AAV-PHP.B
    Davidson, Cristin
    Gibson, Alana
    Gu, Tansy
    Chandler, Randy
    Deverman, Benjamin
    Gradinaru, Viviana
    Venditti, Charles
    Pavan, William
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S36 - S37
  • [20] The First Viable Mouse Model of Combined Methylmalonic Acidemia and Homocystinuria, cblC Type Displays a Sustained Response to a Single Dose of AAV Gene Therapy and is Comparable to Chronic Hydroxocobalamin Administration
    Koutsoukos, Stefanos A.
    Sloan, Jennifer L.
    Murphy, Kelsey C.
    Arnold, Madeline L.
    Achilly, Nathan P.
    Elliot, Gene
    Zerfas, Patricia M.
    Hoffmann, Victoria
    Venditti, Charles P.
    MOLECULAR THERAPY, 2020, 28 (04) : 578 - 578
123